Investing

Top Analyst Upgrades & Downgrades (GENZ, IHS, KSU, MXIM, PBR, RIMM, SLRC, TUP, TKC, VOD)

These are some of this Friday’s top analyst upgrades, downgrades, and initiations seen in Wall Street research calls:

Genzyme Corporation (NASDAQ: GENZ) Cut to Market Perform at Leerink Swann.
IHS Inc. (NYSE: IHS) Started as Buy at Needham & Co.
Kansas City Southern (NYSE: KSU) Started as Overweight at JPMorgan.
Maxim Integrated Products Inc. (NASDAQ: MXIM) Raised to Strong Buy at Needham.
Petroleo Brasileiro (NYSE: PBR) Cut to Hold from Buy at S&P Equity (late yesterday).
Research in Motion Ltd. (NASDAQ: RIMM) Cut to Neutral at Baird; target cut to $70 at Raymond James; target cut to $90 at RBC; target cut to $65 at UBS; target cut to $100 at TD
Solar Capital Ltd. (NASDAQ: SLRC) Started as Outperform at BMO Capital
Tupperware Brands Corporation (NYSE: TUP) Raised to Overweight at JPMorgan.
Turkcell (NYSE: TKC) Raised to Neutral from Sell at UBS.
Vodafone Group plc (NYSE: VOD) Raised to Buy at Collins Stewart.

You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG

Go through the list of the 20 least and most productive and give my take on what they have in common.

Sponsor: 5 best investments for 2010 – The next nine months represent a bold new era for investors.

ALERT: Take This Retirement Quiz Now  (Sponsored)

Take the quiz below to get matched with a financial advisor today.

Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.

Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future

Take the retirement quiz right here.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.